hotspot -WSS

hotspot

author：hotspot 2025-10-01 14:16:09 - browse：96627

Ula Jurkunas, associate director of the cornea service at Mass Eye and Ear, performs the first CALEC surgery. Courtesy Mass Eye and Ear

The first time Phillip Durst saw the big A on the chart, he could hardly believe it. It was the first in a series of letters to check his vision in his left eye. “They keep flipping the chart and it keeps getting smaller and smaller, and I keep identifying the letters — that was huge,” said Durst. “It’s like a miracle.”

A year earlier, in April 2017, Durst had lost sight from that same eye after it was hit by a caustic water treatment solution in a work accident. The damage was so severe that a standard corneal transplant would not resolve it. But in April 2018, he underwent a new, innovative procedure: An eye stem cell transplant led by Ula Jurkunas, the associate director of the cornea service at Mass Eye and Ear in Boston.

Durst, now 51 years old, is the first of four patients who were included in a Phase 1 trial of Cultivated Autologous Limbal Epithelial Cell (CALEC) transplant, the results of which were published Friday in Science Advances. The procedure allowed him to become a suitable candidate for another surgery, the artificial corneal transplant, while rehabilitating his vision — and his life.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： Stroke deaths set to near 10 million globally by 2050

entertainment

WSS

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

Illinois to ban advertising for guns allegedly marketed to kids and militants

Illinois to ban advertising for guns allegedly marketed to kids and militants

Liquid biopsy for lung cancer is launched by Delfi

Moderna hits safety problems in bold bid to reinvent medicine

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

focus

hotspot

focus

Walensky prepares to leave CDC — and Congress — behind

Mississippi candidates for statewide offices square off in party primaries

BioMarin wins approval for gene therapy to treat hemophilia A

At least 12 people were injured in a blast at a port in northwest Turkey

How to save PrEP access — and even expand it

Stroke deaths set to near 10 million globally by 2050

Malaria cases in Florida and Texas: Here’s what you need to know

NYC plans to house migrants on an island in the East River

Anesthesiologist group: stop taking Ozempic before surgery

NYC plans to house migrants on an island in the East River

Wikipedia

FDA rejects Alnylam's heart disease treatment over insufficient data

Liquid biopsy for lung cancer is launched by Delfi

Judges halt a Biden rule offering student debt relief for those alleging colleges misled them

FDA authorizes Novavax’s updated Covid

Sana to lay off nearly a third of staff, de

Biden will tout long

entertainment

hotspot

knowledge

Wikipedia